Ultivue + Vizgen

Where Transcriptomics Meets Proteomics

Ultivue, by Vizgen, is redefining spatial biology by building towards a future where transcriptomics and proteomics are integrated into a complete, clinically-relevant multi-omics solution. The merger between Vizgen and Ultivue will enable scientists to move seamlessly from discovery to clinical applications, accelerating the journey towards high-fidelity biological insights and advancing precision medicine.

Two Leaders. One Company.

1. A More Complete Spatial Biology Ecosystem

By combining Vizgen’s expertise in spatial transcriptomics on the MERSCOPE^® Ultra platform with Ultivue’s spatial proteomics expertise with pathology-grade InSituPlex^® assays and the STARVUE^™ image data science pipeline, researchers now have access to a comprehensive suite of spatial biology solutions from a single team, enabling deeper insights into disease biology with greater precision.

2. Expanded Expertise & Global Reach

A unified scientific, commercial, and support team enhances collaboration, strengthens partnerships, and accelerates discoveries. With a broader global footprint, we’re expanding access to cutting-edge spatial biology tools for broader market segments, spanning academia, CROs, biotech, and biopharma.

3. Smarter Data & AI-Driven Insights

Our proprietary AI-driven image data science strategies enhance biomarker discovery through state-of-the-art generative AI-based models, revealing critical cellular interactions that are often missed with traditional analysis approaches. Backed by an extensive IP portfolio, we are shaping the next era of spatial biology.

4. Seamless Transition from Discovery to Clinical Applications

With high-sensitivity transcriptomics and pathology-grade proteomics, our solutions support scientists from fundamental discovery to biomarker validation and clinical applications, bridging the gap between foundational research and precision medicine.

5. Building the Future of Multi-Omics

Our vision is to create a fully integrated spatial multi-omics platform, allowing scientists to study gene expression and protein function together, unlocking new possibilities in disease research, diagnostics, and precision medicine.